Looking to publish in Vaccine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginVaccine is the official journal of The Japanese Society for Vaccinology and publishes science across vaccinology, including basic and clinical research, vaccine manufacturing, history, public policy, behavioral science, ethics, social sciences, safety, passive immunization, and related areas. It publishes primary Research Papers, Review Articles, Short Communications, Conference Reports, and Letters.
Looking to publish in Vaccine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Vaccine accepts the following article types. Click on an article type to view submission instructions.
Research Article
Review
Short Communication
Letter To The Editor
Recent Publications
Characterization of vaccine viremia, attenuation reversion, and safety: Combined results from the TAK-003 dengue vaccine clinical development program
Vianney Tricou, Xavier Saez-Llorens, Pope Kosalaraksa, Humberto Reynales, Chukiat Sirivichayakul, Charissa Borja-Tabora, Jenny G. Low, William B. Messer, Kelley J. Moss, Sanja Mandaric, Nicholas Roubinis, Mayuri Sharma, Jill Livengood, Hang Pang, Martina Rauscher, Shibadas Biswal
In-depth monitoring of host cell proteins in influenza vaccines throughout multi-step purification processes
Bo Liu, Fang Li, Ying Yang, Hao Tu, Pengliang Hao, Quangang Ma, Yang Le, Qingmei Zhang, Xuedan Li, Ran Qiu, Jiejing Yu, Zhegang Zhang, Shengli Meng, Zhixing Yang, Longjiang Yu
Interim analysis of effectiveness of JN.1-adapted conventional and self-amplifying mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infection in adults aged ≥60 years, Japan, October 2024–April 2025
Haruka Maeda, Ataru Igarashi, Shinya Mitsui, Kenya Suzuki, Tomoko Kutomi, Hiroshi Fujino, Tamehito Onoe, Teruaki Kimura, Yoshihide Ichigi, Hiroyuki Kozai, Toshiaki Komazaki, Satoshi Kida, Azusa Fujisawa, Konosuke Morimoto
Multi-peptide subunit vaccination induced IFN-γ but lacked efficacy against Mycobacterium avium subsp. paratuberculosis in a goat challenge trial
Gitte Erbs, Kari Lybeck, Jeanne Toft Jakobsen, Lien Thi Minh Nguyen, Emilie Sølling Henriksen, Tim John Bull, Claus Aagaard, Stig Tollefsen, Gregers Jungersen
Rubella immunity and vaccination coverage among medical students in Catalonia: a multicentre seroprevalence study
Pau Benito, Marta Aldea, Pere Godoy, Diana Toledo, Irma Casas, Núria Soldevila, Rosa Bartolomé, Angela Domínguez
Frequently asked questions
How long does it take to publish?
Proof corrections are requested within two days after proofs are sent.
Reformat to Vaccine using Livewrite PremiumIs a cover letter required?
A cover letter should be included with submission. It should be short, focused, explain the study's aim and main findings, show fit with the journal’s aims and scope, emphasize novelty and broader implications, and acknowledge an invitation if applicable. Funding information, author declarations, and suggested or opposed reviewers should not be included.
Reformat to Vaccine using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3680 excluding taxes for all articles. Subscription publication has no open access publication fee.
Reformat to Vaccine using Livewrite Premium